Venofer® Reimbursement Hotline: 1-800-282-7712
FOR NON-DIALYSIS FACILITIES AND PROVIDERS ONLY

American Regent, Inc. has created a toll-free hotline to help physicians and other providers understand payer’s coverage and reimbursement policies for Venofer® (iron sucrose injection, USP) and, when necessary, address reimbursement issues. Specifically, hotline Reimbursement Specialists assist with the following:

  • Insurance verifications. Help callers verify payer coverage and reimbursement policies for Venofer® for specific patients with patient consent. Reimbursement specialists will determine patients’ benefits level and discuss potential billing options.
  • Billing assistance. Assist callers with filing claims and understanding the reimbursement policies for Venofer®, including researching state-specific local codes.
  • Claims appeals. Support callers in appealing denied claims or inadequate reimbursement for Venofer®.
  • Patient assistance. Screen individuals with no health insurance who are ineligible for public assistance for enrollment in a free product replacement program.




Instructions on Using the Reimbursement Hotline

  • Hours of operation are Monday through Friday from 9:00 AM to 5:00 PM, Eastern time. Call toll-free 800-282-7712 
  • A Reimbursement Specialist answers most calls. There may be times when you need to leave a message that includes your name, telephone number, and a brief summary of your question or request. Calls are returned on the same day, or within one business day whenever possible
     
  • During your call, you will be asked to provide the following information:
    - Name and telephone number(s) of the patient's primary and secondary third-party payer(s)
    - Patient's name, date of birth, policy holder's name, and policy number(s)
    - Your reimbursement questions




Patient information will be kept strictly confidential at all times

The Reimbursement Specialist will either provide you with the information you request or will contact the insurer for clarification. The Reimbursement Specialist will call you back with the information you requested.

Every attempt is made to provide accurate, up-to-date information. The Venofer® Reimbursement Hotline cannot guarantee successful reimbursement.

For more details about coverage and reimbursement, call the Venofer® Reimbursement Hotline at 800-282-7712, Monday through Friday, 9:00 AM to 5:00 PM, Eastern time.

For Customer Service or Professional Services Departments, call 800-645-1706.
American Regent. Enriching the lives of anemia patients. ™

IMPORTANT SAFETY INFORMATION:

Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Venofer® (iron sucrose injection, USP). Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. If hypersensitivity reactions or signs of intolerance occur during administration, stop Venofer® immediately. Monitor patients for signs and symptoms of hypersensitivity during and after Venofer® administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Venofer® when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions.

Venofer® may cause clinically significant hypotension. Monitor for signs and symptoms of hypotension following each administration of Venofer®. Hypotension following administration of Venofer® may be related to rate of administration and total dose delivered.

Venofer® is contraindicated in patients with known hypersensitivity to Venofer®. Do not administer to patients with evidence of iron overload.

In efficacy studies in non-dialysis dependent-CKD patients (N=139), the most frequent adverse events (≥5%) whether or not related to Venofer® administration, were nausea (8.6%), taste disturbance

(7.9%), peripheral edema (7.2%), diarrhea (7.2%), dizziness (6.5%), hypertension (6.5%), infusion site pain or burning (5.8%), dyspnea (5.8%), and vomiting (5.0%).

In multi-dose efficacy studies in HDD-CKD patients (N=231), the most frequent adverse events (> 5%) whether or not related to Venofer® administration, were hypotension (39.4%), muscle cramps (29.4%), nausea (14.7%), headache (12.6%), graft complications (9.5%), vomiting (9.1%), dizziness (6.5%) hypertension (6.5%), chest pain (6.1%), and diarrhea (5.2%). In the study of PDD-CKD patients (N=75), the most frequent adverse events, whether or not related to Venofer®, reported by ≥5% of these patients were infections and infestations (nasopharyngitis, sinusitis, upper respiratory tract, pharyngitis) (16.0%), diarrhea (8.0%), vomiting (8.0%), hypertension (8.0%), peripheral edema (5.3%), and nausea (5.3%).


Please see Full Prescribing Information.